Sign In
7 Dec 2011 11:48
ο»Ώ
Ark Therapeutics Group plc
Β
Director's Share Dealing
Β
Β
Ark Therapeutics Group plc (LSE: AKT) ("Ark" or the "Company") announces that it was informed on 6 December by Mr Peter Keen, a Non-Executive Director of Ark, that he had transferred 11,765 ordinary shares of 1p each in the Company into a Self Invested Personal Pension ("SIPP"). Accordingly, on 6 December, 11,765 ordinary shares were sold by Mr Keen at a price of 3.85 pence per share and 11,765 ordinary shares were bought by the SIPP at the price of 3.85 pence per share.
Β
Following these transactions, there has been no change in Mr Keen's interest in the Company's ordinary shares.
Β
Β
For further information please contact:
Β
Ark Therapeutics Group plc | +44 (0)20 7388 7722 |
Dr Edward Bliss, Company Secretary |
Β
Β
Follow the stocks
